Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
120 Mason Farm Road
Chapel Hill, NC 27599Phone+1 919-966-2356Fax+1 919-966-6714- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterFellowship, Infectious Disease, 1977 - 1979
- University of Michigan Health SystemResidency, Internal Medicine, 1974 - 1977
- Rush Medical College of Rush University Medical CenterClass of 1974
- University of IllinoisB.S., Summa Cum Laude, 1969 - 1971
Certifications & Licensure
- NC State Medical License 1980 - 2024
- MI State Medical License Active through 1979
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- National Academy of Medicine 2012
- Association of American Physicians 2007
- Faculty Service Award UNC General Alumni Association, 2015
- Join now to see all
Clinical Trials
- Preventing Sexual Transmission of HIV With Anti-HIV Drugs Start of enrollment: 2005 Feb 01
- Acute HIV Infection Observational Study Start of enrollment: 2006 Jun 01
Publications & Presentations
PubMed
- In Memoriam: Dr. Adaora Alise Adimora.Walensky, R., Agwu, A., Cohen, M.> ;Clinical Infectious Diseases. 2024 Jan 31
- Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.Juraska, M., Bai, H., deCamp, A., Magaret, C., Li, L., Gillespie, K., Carpp, L., Giorgi, E., Ludwig, J., Molitor, C., Hudson, A., Williamson, B., Espy, N., Simpkins, B...> ;Proceedings of the National Academy of Sciences of the United States of America. 2024 Jan 23
- High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.Reeves, D., Mayer, B., deCamp, A., Huang, Y., Zhang, B., Carpp, L., Magaret, C., Juraska, M., Gilbert, P., Montefiori, D., Bar, K., Cardozo-Ojeda, E., Schiffer, J., Ro...> ;Nature Communications. 2023 Dec 14
- Join now to see all
Journal Articles
- Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize ImpactConnie Celum, Myron S Cohen, Wafaa El-Sadr, The New England Journal of Medicine
- Monoclonal Antibodies for Prevention and Treatment of COVID-19John R Mascola, Myron S Cohen, JAMA
- Hydroxychloroquine for the Prevention of Covid-19 — Searching for EvidenceMyron Cohen, MD, The New England Journal of Medicine
- Join now to see all
Books/Book Chapters
Lectures
- HIV Vaccines (X2)Keystone Symposia, Keystone, Colorado - 2/10/2013
- B Cell Development and Function (X1)Keystone Symposia, Keystone, Colorado - 2/10/2013
- HIV Management 2012: The New York CourseThe New York Course : HIV Management, New York, New York - 5/10/2012
Other
- PEPFAR, Launched as an Emergency Response to AIDS, Has Built a Bridge to the FutureMyron Cohen, MD, STAT
https://www.doximity.com/articles/04aeec55-0bc9-42e4-b378-30c377f7ecc1
UpToDate, Wolters Kluwer Health - 2012-11-26 - Syndromic treatment of gonococcal and chlamydial infection in women seeking primary care for genital discharge syndrome: decision-making.Behets F, Miller WC, Cohen MS, Bulletin of the World Health Organization
1/1/2001 - Approaches to control sexually transmitted diseases Haiti from 1992 through 1995.Behets F, Genece E, Narcisse M, Dallabetta G, Cohen MS, WHO Bulletin
1/1/1998 - Join now to see all
Authored Content
- Monoclonal Antibodies for Prevention and Treatment of COVID-19June 2020
- Hydroxychloroquine for the Prevention of Covid-19 — Searching for EvidenceJune 2020
- Hydroxychloroquine for the Prevention of Covid-19 — Searching for EvidenceJune 2020
- PEPFAR, Launched as an Emergency Response to AIDS, Has Built a Bridge to the FutureNovember 2018
- Join now to see all
Press Mentions
- A Valuable COVID Drug Won’t Work Against New VariantJanuary 4th, 2023
- A Valuable COVID Drug Doesn&Rsquo;T Work Against New VariantsJanuary 3rd, 2023
- Bug Bites and Infectious Diseases: What to KnowNovember 2nd, 2022
- Join now to see all
Grant Support
- HIV In Semen-Effects Of STDS And Antiviral TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2012
- Acute HIV-1 Infections Network CoreNational Institute Of Allergy And Infectious Diseases2006–2009
- Acute HIV And STDS In MalawiNational Institute Of Allergy And Infectious Diseases2004–2008
- Infectious Disease Pathogenesis Research TrainingNational Institute Of Allergy And Infectious Diseases1998–2007
- Acute HIV-1 Infections Network CoreNational Institute Of Allergy And Infectious Diseases2005
- HIV-1 In Plasma And Semen Of Men On HaartNational Center For Research Resources2004–2005
- Effects Of Antiretroviral Therapy On The Excretion Of HIV In SemenNational Center For Research Resources2004
- HIV In Semen--Effects Of STDS And Antiviral TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
- Core--Microbiology FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
- Core--Human Challenge FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
- Human Challenge Study Of Isogenic Mutants Of Neisseria GonorrhoeaeNational Center For Research Resources1996–2002
- Study Of Isogenic Mutants Of Neisseria GonorrhoeaeNational Center For Research Resources2000
- Intrasubject Variability Of Excretion Of HIV In Semen Over TimeNational Center For Research Resources2000
- Sexually Transmitted Diseases Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1997–2000
- HIV In Semen--Effects Of STDSNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Reaching HIV Through Gonorrhea--Network ApproachFogarty International Center1998
- Core--Clinical/MicrobiologyNational Institute Of Allergy And Infectious Diseases1995–1998
- A Challenge Study Of Neisseria GonorrhoeaeNational Institute Of Allergy And Infectious Diseases1995–1998
- Inoculation Of Mutants Into UrethraNational Institute Of Allergy And Infectious Diseases1994
- Core--MicrobiologyNational Institute Of Allergy And Infectious Diseases1994
- Phagocytes, Free Radicals And Cellular ConsequencesNational Institute Of Allergy And Infectious Diseases1989–1991
Hospital Affiliations
- University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: